Advances in colon-targeted nano-drug delivery systems: challenges and solutions.

Abstract

Nano-drug delivery systems (NDDS) for colon-targeted drug delivery are an active area of research on local diseases affecting the colon, such as ulcerative colitis, Crohn's disease, colon cancer, and for the delivery of peptide or protein drugs and vaccinations. In particular, targeted nano-drug delivery to the colon is advantageous for colon-specific diseases because nanoparticles can accumulate in diseased parts, improve the efficacies of therapeutics, and enable localized treatments, which reduces systemic toxicity. However, there are many hurdles, such as burst drug release, enzyme and acidic degradation of drug and carrier in the stomach, pH variations, mucus entrapment, and systemic uptake in the upper small intestine, which could challenge and compromise the successful delivery of NDDS to the colon. With advancements in NDDS, it may be possible to overcome these challenges leading to efficient drug delivery for colon-specific disorders. This review describes a few of the potential colon-specific drug delivery areas and the challenges faced by colon-targeted orally administered delivery systems, and provides an updated summary of recent advances in the development of orally administered NDDS for colon targeting, and the future advances in this research.

• Authors: Muhammad Naeem, Uzma Azeem Awan, Fazli Subhan, Jiafu Cao, Shwe Phyu Hlaing, Juho Lee, Eunok Im, Yunjin Jung, Jin-Wook Yoo
• Journal: Archives of pharmacal research (Arch Pharm Res) Vol. 43 Issue 1 Pg. 153-169 (Jan 2020) ISSN: 1976-3786 [Electronic] Korea (South)
• PMID: 31989477 (Publication Type: Journal Article, Review)

Chemical References

• Drug Carriers

Topics

• Animals
• Colonic Diseases (drug therapy, metabolism)
• Drug Carriers (administration & dosage, chemistry)
• Drug Delivery Systems
• Drug Liberation
• Humans
• Hydrogen-Ion Concentration
• Nanoparticles (administration & dosage, chemistry)